Dostarlimab

Definition: Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. Dostarlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody. The most common side effects reported in the US include fatigue/asthenia, nausea, diarrhea, anemia, and constipation. source: Wikipedia

ID

1156877005

ID date

20 Jun 2022

Previous ID

40395211000001108

Name

Dostarlimab